Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/7/2015 |
| Start Date: | September 2014 |
A Multicentre, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Three Doses of Botulinum Toxin in the Treatment of Moderate to Very Severe Glabellar Frown Lines
The primary objective of the study is to evaluate the efficacy in wrinkle reduction of a
single treatment of three different doses of botulinum toxin compared to placebo, in the
treatment of moderate to very severe glabellar frown lines.
single treatment of three different doses of botulinum toxin compared to placebo, in the
treatment of moderate to very severe glabellar frown lines.
Inclusion Criteria:
- Moderate to Very Severe glabellar lines at maximum frown as assessed by the subject
and the Investigator and at least Mild glabellar lines at rest
Exclusion Criteria:
- Any previous treatment with any botulinum toxin
- Rhytids of the glabellar region that cannot be smoothed out by manually spreading the
skin apart
- Any previous insertion of any permanent or semi-permanent material, hyaluronic acid
or collagen fillers to the glabellar region
- Any history of facial surgery above the lower orbital rim
- Any planned facial surgery or aesthetic procedure during the study period
- Ablative skin resurfacing or chemical peels above the lower orbital rim in the
previous 12 months or during the study period
We found this trial at
8
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials